Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Letrozole × Other × Clear all

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Breast 24 Other 1

Conditions

Obesity 1 Breast Neoplasms 1 Arthralgia 1

Interventions

Surveys and Questionnaires 8 Blood Specimen Collection 5 Therapeutics 3 Observation 3 Interviews as Topic 3 Bariatric Surgery 3 semaglutide 2 naloxegol 2 naldemedine 2 exemestane 2 Tirzepatide 2 Tamoxifen 2 Psychiatric Rehabilitation 2 Paclitaxel 2 Hematologic Tests 2 Esophagectomy 2 Echocardiography 2 Carboplatin 2 Biopsy 2 BaseLine dental cement 2 Anastrozole 2 trametinib 1 sotorasib 1 selpercatinib 1 pembrolizumab 1 osimertinib 1 lorlatinib 1 dabrafenib 1 cemiplimab 1 bupropion hydrochloride, naltrexone hydrochoride drug combination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01896050 2016-06-28

LOGRIBMET

University of Michigan Rogel Cancer Center

115 enrolled 14 charts

Breast Neoplasms, Obesity, Arthralgia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡